Pharmacy Times November 4, 2024
Maria Roberts, PharmD, Angie Oster, PharmD

Key Takeaways

  • Breast cancer incidence is rising, with invasive ductal carcinoma as the most common type, necessitating personalized treatment plans based on tumor characteristics and staging.
  • Social determinants of health (SDOH) significantly influence breast cancer treatment adherence and outcomes, with digital and health literacy being major factors.
  • Pharmacists play a crucial role in managing breast cancer treatment by providing education, monitoring adverse drug events, and addressing SDOH to improve adherence and outcomes.
  • Pharmacist interventions can lead to improved patient satisfaction, adherence to oral oncolytics, and overall quality of life for breast cancer patients.

Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.

Rates of breast cancer...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Equity/SDOH, Healthcare System, Patient / Consumer, Provider
Related Articles:
San Francisco hospital receives health equity award from Kaiser, Joint Commission
Inequality in health outcomes in the US: Can we measure this?
Podcast: AAMC Is Working To Thread Healthy Outcomes Through Health Equity
A Year of Bold Progress: IFDHE's Journey Towards Health Equity in 2024
U.S. Has Made Little Progress With Health Equity, Expert Says

Share This Article